Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Taraboletti

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Oncogene|November 13, 2001
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesisF Vikhanskaya, M R Bani, P Borsotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenograftsR Giavazzi, A Garofalo, C Ferri, et al.
British Journal of Cancer|June 3, 2004
Antiangiogenic activity of aplidine, a new agent of marine originG Taraboletti, M Poli, R Dossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activityC Gatto, M Rieppi, P Borsotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1987
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude miceA Benomar, W J Ming, G Taraboletti, et al.
Leukemia|January 17, 2003
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4M Broggini, S V Marchini, E Galliera, et al.
International Journal of Cancer|January 9, 2001
Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomasV Vergani, A Garofalo, M R Bani, et al.
Biochimica Et Biophysica Acta|February 5, 2000
CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2M Molino, M J Woolkalis, N Prevost, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1997
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune miceC Zoja, X H Liu, R Donadelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular TatM Rusnati, G Taraboletti, C Urbinati, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Oncogene|November 13, 2001
p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesisF Vikhanskaya, M R Bani, P Borsotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenograftsR Giavazzi, A Garofalo, C Ferri, et al.
British Journal of Cancer|June 3, 2004
Antiangiogenic activity of aplidine, a new agent of marine originG Taraboletti, M Poli, R Dossi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
BAY 12-9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activityC Gatto, M Rieppi, P Borsotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1987
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude miceA Benomar, W J Ming, G Taraboletti, et al.
Leukemia|January 17, 2003
Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4M Broggini, S V Marchini, E Galliera, et al.
International Journal of Cancer|January 9, 2001
Inhibition of matrix metalloproteinases by over-expression of tissue inhibitor of metalloproteinase-2 inhibits the growth of experimental hemangiomasV Vergani, A Garofalo, M R Bani, et al.
Biochimica Et Biophysica Acta|February 5, 2000
CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2M Molino, M J Woolkalis, N Prevost, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1997
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune miceC Zoja, X H Liu, R Donadelli, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 12, 2000
Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular TatM Rusnati, G Taraboletti, C Urbinati, et al.
Pageof 6